Burning Rock Biotech Stock (NASDAQ: BNR) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 6.28K |
Day Range | - - - |
52 Wk Range | 2.70 - 11.70 |
Market Cap | $32.42M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 28 |
Short Interest | 0.45% |
Days to Cover | 4.95 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Burning Rock Biotech (NASDAQ:BNR) through any online brokerage.
Other companies in Burning Rock Biotech’s space includes: Fortress Biotech (NASDAQ:FBIO), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX) and OncoCyte (NASDAQ:OCX).
There is no analysis for Burning Rock Biotech to provide a consensus price target.
The stock price for Burning Rock Biotech (NASDAQ: BNR) is $3.16 last updated September 23, 2024 at 8:41 AM EDT.
There are no upcoming dividends for Burning Rock Biotech.
Burning Rock Biotech’s Q3 earnings are confirmed for Friday, November 29, 2024.
There is no upcoming split for Burning Rock Biotech.
Burning Rock Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.